These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15183501)

  • 1. Production and killing of second cancer precursor cells in radiation therapy: in regard to Hall and Wuu (Int J Radiat Oncol Biol Phys 2003;56:83-88).
    Davis RH
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):916. PubMed ID: 15183501
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose-response relationship for radiation-induced cancer--decrease or plateau at high dose: in regard to Davis (Int J Radiat Oncol Biol Phys 2004;59:916).
    Schneider U
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):312-3; author reply 313. PubMed ID: 15629639
    [No Abstract]   [Full Text] [Related]  

  • 3. Calculated risk of fatal secondary malignancies from intensity-modulated radiotherapy: In regard to Kry et al. (Int J Radiat Oncol Biol Phys 2005;62:1195-1203).
    Schneider U
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1290; author reply 1290-1. PubMed ID: 16504771
    [No Abstract]   [Full Text] [Related]  

  • 4. In regard to letter by Muscoplat et al.: Radiation therapy for inflammatory arthritis (Int J Radiat Oncol Biol Phys 2004;60:688-689).
    Dimitroyannis D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):961. PubMed ID: 15708281
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantification of the contribution of hyperthermia to results of cervical cancer trials: in regard to Plataniotis and Dale (Int J Radiat Oncol Biol Phys 2009;73:1538-1544).
    Crezee J; Barendsen GW; Westermann AM; Hulshof MC; Haveman J; Stalpers LJ; Geijsen ED; Franken NA
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):634; author reply 634-5. PubMed ID: 19735894
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiation-induced malignant gliomas: is there a role for reirradiation? In regard to Paulino et Al. (Int j radiat oncol biol phys epub 2008 feb 8).
    Bahl A; Sharma DN; Kumar M; Basu KS; Rath GK
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):304-5; author reply 305. PubMed ID: 18722290
    [No Abstract]   [Full Text] [Related]  

  • 7. In regard to Vordermark et al. (Int J Radiat Oncol Biol Phys 2004;58:1242-1250).
    Koch CJ
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):1003-4; author reply 1004-5. PubMed ID: 15465220
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of TGF-beta1 plasma levels: In regard to Anscher et al. (Int J Radiat Oncol Biol Phys 2003;56: 988-995) and de Jaeger et al (Int J Radiat Oncol Biol Phys 2004;58: 1378-1387).
    Barthelemy-Brichant N
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1339; author reply 1339-40. PubMed ID: 15519811
    [No Abstract]   [Full Text] [Related]  

  • 9. The need and prospect of individualized external beam radiotherapy dose escalation beyond 80 gy to treat prostate cancer: in regard to Eade et al. (Int J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
    Cheung MR
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207039
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052).
    Russi EG; Pergolizzi S; Lucio F; Ricardi U
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1273-4; author reply 1274. PubMed ID: 17145545
    [No Abstract]   [Full Text] [Related]  

  • 11. In regard to Marcié et al.: in vivo measurements with MOSFET detectors in oropharynx and nasopharynx intensity-modulated radiation therapy (Int J Radiat Oncol Biol Phys 2005;61:1603-1606).
    Ayyangar K; Nehru R; Djajaputra D; Zhen W; Enke C
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):310-1; author reply 311. PubMed ID: 16111605
    [No Abstract]   [Full Text] [Related]  

  • 12. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
    Yaeger TE
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
    [No Abstract]   [Full Text] [Related]  

  • 13. A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer: in regard to Diez P, et al. (Int J Radiat Oncol Biol Phys 2010;77:1066-1071).
    Williams SG
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):639; author reply 639-40. PubMed ID: 21549251
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy: In regard to Anscher et al. (Int J Radiat Oncol Biol Phys 2005;62:255-259).
    Sminia P; Mayer R; van der Kleij A; Feldmeier J
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):649-50; author reply 650. PubMed ID: 16168862
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiation fields of neoadjuvant concurrent chemoradiotherapy for rectal cancer: in regard to Yu et al. (Int J Radiat Oncol Biol Phys 2008;71:1175-1180).
    Chien CR; Chen SW; Chen WT
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):639; author reply 639-40. PubMed ID: 19147033
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose-rate effects when estimating risks for second malignancies: in regard to Fontenot et al (Int J Radiat Oncol Biol Phys 2009;74:616-622).
    Paganetti H; Athar BS; Bednarz B
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1624; author reply 1624-5. PubMed ID: 19931743
    [No Abstract]   [Full Text] [Related]  

  • 17. Re-irradiation for recurrent head and neck cancer: in regard to Lee et Al. (Int j radiat oncol biol phys 2007;68:731-740).
    Nieder C
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1652-3; author reply 1653. PubMed ID: 18035224
    [No Abstract]   [Full Text] [Related]  

  • 18. Neutron dose in proton radiation therapy: in regard to Eric J. Hall (Int J Radiat Oncol Biol Phys 2006;65:1-7).
    Paganetti H; Bortfeld T; Delaney TF
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1594-5; author reply 1595. PubMed ID: 17126219
    [No Abstract]   [Full Text] [Related]  

  • 19. Linear quadratic modeling of increased late normal-tissue effects in special clinical situations: in regard to Jones et al. (Int J Radiat Oncol Biol Phys 2006;64:948-953).
    Mandal A
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):631; author reply 631-2. PubMed ID: 16966009
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiobiological parameters suitable for modeling individual outcomes cannot be obtained by analyzing heterogeneous population data with homogeneous tumor control model: in regard to D'Souza et al. (Int J Radiat Oncol Biol Phys 2004;58:1540-1548).
    Carlone M; Wilkins D; Raaphorst GP
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):298-9. PubMed ID: 15850946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.